| | |||||
| lung cancer | |||||
| 新闻 | |||||
| Zoldonrasib Elicits Objective Responses in Patients With KRAS G12D-mutated Lung Cancer lung cancer (NSCLC) whose tumors harbored a KRAS G12D mutation experienced clinical benefit from the oral KRAS G12D inhibitor zoldonrasib ...
| |||||
| Committee Cliff Notes: Weekly Preview – Week of April 28, 2025 | Majority Leader 2319, the Women and Lung Cancer Research and Preventive Services Act of 2025 (Boyle); H.R. 1669, To amend the PHSA to reauthorize the SOAR to ...
| |||||
| 查看更多结果 | 修改此快讯 | |||||
| 您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
| 发送反馈 |
No comments:
Post a Comment